Moderna Inc (MIL:1MRNA)
€ 38.165 -0.445 (-1.15%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 44/100

Moderna Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript

Sep 18, 2020 / 02:05PM GMT
Geoffrey Christopher Meacham
BofA Securities, Research Division - MD

Okay. Good morning, everyone. I'm Geoff Meacham. I'm the senior biopharma analyst here at Bank of America. I have also for my team, Alec Stranahan. And welcome to the BofA London Healthcare Conference. We have a great session for you today. We have Moderna with us. And speaking on behalf of Moderna, we have CEO, Stéphane Bancel.

So the format for today is just a fireside chat. And we do have access to the Veracast technology. If you want to log in a question, I can see questions in the queue and then I can read those out as well.

So with that, Stéphane, I'll turn it over to you just to kick it off with a couple of -- maybe a recap from yesterday, and we -- and Alec, I can get right into questions after that.

Stephane Bancel
Moderna, Inc. - CEO & Director

Great. Super. Thanks, Geoff, and thanks for having us. So good morning or good afternoon, everybody. I think a quick recap of the Annual R&D Day of Moderna, which happened yesterday. On the vaccine front, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot